ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

オロパタジン塩酸塩

Olopatadine Hydrochloride

HCID 5282402
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
140462-76-6
標準SMILES
CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl
InChIKey
HVRLZEKDTUEKQH-NOILCQHBSA-N
分子式
C21H24ClNO3
平均分子量
373.9 g/mol
単同位体質量
373.14447131

概要

Olopatadine hydrochloride is a dibenzooxazepine.

名称と識別子

優先名称
Olopatadine Hydrochloride
IUPAC
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
現地名
オロパタジン塩酸塩
英語名
Olopatadine hydrochloride
分子式
C21H24ClNO3
分子量
373.88

名称と別名

OLOPATADINE HYDROCHLORIDE140462-76-6OLOPATADINE HClPatadayAllelockPatanasePazeoALO4943AKW4679DTXSID0046486KW-4679ALO-4943A
名称をさらに表示
オロパタジン塩酸塩オロパタジン 塩酸塩オロパタジン塩酸塩錠オロパタジン塩酸塩 (JP17)オロパタジン塩酸塩錠 (JP17)アレロックオロパタジン・塩酸塩パタノールドキセパジン6,11-ジヒドロ-11-[(Z)-3-(ジメチルアミノ)プロピリデン]ジベンゾ[b,e]オキセピン-2-酢酸・塩酸塩オパタノールパタデイ(Z)-2-[11-[3-(ジメチルアミノ)プロピリデン]-6,11-ジヒドロジベンゾ[b,e]オキセピン-2-イル]酢酸=塩酸塩塩酸オロパタジン2-[11-[(Z)-3-(ジメチルアミノ)プロピリデン]-6,11-ジヒドロジベンゾ[b,e]オキセピン-2-イル]酢酸・塩酸塩Olopatadin HCLOLAPATADINE HCLPatanolOlopatadine HydrochlordeDibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-OpatanolAL-4943AOLOPATDINEHYDROCHLORIDE
Olopatadine (as hydrochloride)2XG66W44KFDTXCID8026486Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-RYALTRIS COMPONENT OLOPATADINE HYDROCHLORIDERetaine AllergyOnce Daily ReliefRefChem:56800

物性

構造計算による物性

極性表面積
49.8 Ų
水素結合供与体数
2
水素結合受容体数
4
回転可能結合数
5
重原子数
26
形式電荷
0
複雑度
488

実験および物理化学的性質

Human Drugs · 3 件

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

物理化学的性質

融点
242 · 242-245C
貯蔵温度
Inert atmosphere,Room Temperature
溶解性
2 O: · H2O: ≥20mg/mL
外見
個体
色
White to Light yellow
水溶解度
2 O: · H2O: ≥20mg/mL
Merck
14 · 14,6840
BCS Class
3 · 3(CLogP), 1 (LogP)
InChI
InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;
InChIKey
HVRLZEKDTUEKQH-NOILCQHBSA-N
SMILES
C(=C1/C2=CC=CC=C2COC2C=CC(CC(=O)O)=CC/1=2)\CCN(C)C.Cl
CAS データベース
140462 · 140462-76-6(CAS DataBase Reference)

化学的性質

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 4.3% (2 of 47) of reports.

Danger

H301 (87.2%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P273, P301+P316, P321, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 47 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 3 (87.2%)

毒性情報

Exposure RoutesOphthalmic use of olopatadine usually does not produce measurable plasma concentrations.
Toxicity Summary · 1 件

Olopatadine is a selective histamine H1 antagonist that binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Olopatadine is devoid of effects on alpha-adrenergic, dopamine and muscarinic type 1 and 2 receptors.

Signs and Symptoms · 1 件

Its side effects may include headaches (7% of occurrence) burning and stinging (5%), dry eye, foreign body sensation, hyperemia, keratitis, lid edema, pruritus, asthenia, cold syndrome, pharyngitis, rhinitis, sinusitis, and taste perversion. [Wikipedia]

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

安全データ

化学と産業

薬理情報

Metabolism/MetabolitesThe mono-desmethyl and the N-oxide metabolites have been detected at low concentrations in the urine. Route of Elimination: Elimination was predominantly through renal excretion. Half Life: 3 hours
FDA Pharmacological Classification · 6 件

OLOPATADINE HCL

Decreased Histamine Release [PE]; Mast Cell Stabilizer [EPC]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Histamine H1 Receptor Antagonists [MoA]

OLOPATADINE HYDROCHLORIDE

Mast Cell Stabilizer [EPC]; Decreased Histamine Release [PE]; Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Inhibitor [EPC]

OLOPATADINE HYDROCHLORIDE OPHTHALMIC

Decreased Histamine Release [PE]; Mast Cell Stabilizer [EPC]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Histamine H1 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 3 件

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.

関連反応

2 件
反応記録を作成
HRID 422887 の反応式
HRID 422887反応物として
HRID 2247135 の反応式
HRID 2247135生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
140462-76-6
PubChem CID
5282402
DTXSID
DTXSID0046486
ChEMBL
CHEMBL1719
ChEBI
CHEBI:31933
UNII
2XG66W44KF
EC Number
604-185-4

化学的特性White Solid

wgk
3
rtecs
HQ4135060
ridadr
UN 2811 6.1 / PGIII
hs_code
29329990
risk_code
25-50
hazard_code
T,N
safety_code
45-61
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

用途と製造

UsesFor the treatment of ocular itching associated with allergic conjunctivitis. Used as an antihistamine. [Wikipedia]
応用分野 · 2 件

説明Olopatadine hydrochloride is an ophthalmic antihistamine that inhibits release of histamine from mast cells and is a relatively selective histamine H1 antagonist. It inhibits type 1 immediate hypersensitivity reactions. Olopatadine hydrochloride is indicated in the temporary relief of itching caused by allergic conjunctivitis. H1 antagonists have an established and valued place in the symptomatic treatment of various immediate hypersensitivity reactions. In addition, the central properties of some of the series are of therapeutic value for suppressing motion sickness or for sedation.

使用Olopatadine hydrochloride is a potent, selective antagonist of the H1 histamine receptor (Ki = 16-41.1 nM), with much lower affinities for the H2 and H3 receptors (Ki = 43.4 and 172 μM, respectively). It blocks histamine-induced phosphoinositide turnover in isolated cells (IC50 = 9.5-39.9 nM) and prevents passive cutaneous anaphylaxis in rats (ED50 = 49 μg/kg) and anaphylactic bronchoconstriction in guinea pigs (ID50 = 30 μg/kg). Olopatadine is effective in treating allergic rhinitis and conjunctivitis. It also suppresses itch in patients with well-controlled chronic urticaria. In humans, this antihistamine does not cause cognitive or psychomotor impairment at therapeutic doses.[Cayman Chemical]

上流・下流製品情報

上流原料

Olopatadine Ethyl Ester[3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide[3-(ジメチルアミノ)プロピル]トリフェニルホスホニウム ブロマイドオロパタジンイソキセパクUGDFSHGFPJSALM-OCKHKDLRSA-NChloro[3-(dimethylamino)propyl]magnesiumN,N-ジメチル-3-クロロ-1-プロパンアミン

下流製品

(E)-オロパタジン塩酸塩